Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank31
3Y CAGR-78.0%
5Y CAGR-50.9%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-78.0%/yr
vs -0.4%/yr prior
5Y CAGR
-50.9%/yr
Recent deceleration
Acceleration
-77.6pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $192000.00 | -56.5% |
| 2024 | $441000.00 | -77.1% |
| 2023 | $1.92M | -89.3% |
| 2022 | $18.05M | +234.4% |
| 2021 | $5.40M | -19.4% |
| 2020 | $6.70M | -0.8% |
| 2019 | $6.75M | -63.2% |
| 2018 | $18.33M | -34.1% |
| 2017 | $27.81M | +2312.2% |
| 2016 | $1.15M | - |